Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Fourth Unveils First Annual “Truth about Dining Out” Survey Results, Revealing Americans’ Eating-out Habits, the Rise of Third-Party Delivery Apps and Favorite Celebrity Chef

Published

on

Reading Time: 5 minutes

Survey reveals new findings around the attitudes and expectations of
today’s restaurant patrons, enabling restaurant operators to boost
customer loyalty and develop winning strategies

TAMPA, Fla.–(BUSINESS WIRE)–Fourth,
the provider of the industry’s leading hospitality operations platform,
today revealed the findings of its first annual “Truth about Dining Out”
survey. With the goal of providing restaurant operators an inside look
at how Americans prefer to eat out, the survey, conducted by OnePoll and
commissioned by Fourth, shows that quality of service is oftentimes more
important than the actual meal among respondents who dine out. The
survey results reinforce that engaged staff are happier, provide better
service, create loyal customers and increase sales.

Americans Love Eating Out

With a strong U.S. economy, consumers continue to spend money eating out
rather than cooking meals at home. In fact, the survey results showed
that more than half (56 percent) of respondents who eat out – which
includes eating in restaurants, ordering food to-go and delivery – eat
out at least 2-3 times per week. Additionally, 10 percent of Americans
said they eat out 4-6 times per week, and 6 percent of consumers cited
they eat out every day.

  • When broken down to gender, the survey found that men typically spend
    more per week eating out ($82) while women spend $69. In fact, 10
    percent of men eat out every day compared to only 2 percent of women.
  • Respondents who earn between $40,001 – $50,000 per year spend the most
    money eating out, averaging $117.82 per week or between 12.25 percent
    to 15.31 percent of their yearly income.

The survey also examined, through multiple-answer questions, why
consumers eat out at a restaurant. Forty-seven percent of respondents
selected “social, spending time with family and friends” as the main
reason, followed by “special occasion” (41 percent), “it’s convenient”
(40 percent) and “I enjoy the atmosphere” (33 percent).

Gordon Ramsay – America’s Favorite Celebrity Chef

With the ongoing popularity in celebrity cooking shows and competitions,
the survey asked respondents to select their favorite celebrity chef.
According to the results, Gordon Ramsay took the number one spot with 11
percent of the votes, followed by Anthony Bourdain (7 percent) and Bobby
Flay (6 percent).

  • Gordon Ramsay was the favorite celebrity chef among respondents
    between the ages of 18-54. Surprisingly, Emeril Lagasse was the top
    pick for respondents who are 55 and older.
  • When broken down to region, respondents in the West selected Anthony
    Bourdain (13 percent) as their favorite celebrity chef with 13 percent
    of respondents citing “known celebrity chef” as an important factor
    when selecting a restaurant.

Customer Loyalty Begins with a Smile

As restaurants compete for customers, providing superior service is no
longer an added bonus, but expected. More than half of survey
respondents (53 percent) cited “good service” as the second most
important factor when selecting a restaurant following “food quality”
(62 percent), which received the most votes.

  • When determining a server’s tip, 58 percent of respondents cited
    “friendly and pleasant demeanor” as the most important factor followed
    by “attentiveness” (50 percent) and “accuracy of order” (44 percent).
  • Nearly a third of respondents (30 percent) cited “rude restaurant
    service” as their biggest frustration when eating out at a restaurant.
  • When asked to pick one thing that you would generally change in
    restaurants, the majority of open-ended responses included complaints
    around bad service.
  • When discovering new restaurants, 59 percent of respondents rely on
    “friend recommendations,” followed by “social media” (46 percent),
    reinforcing that great customer service and maintaining a good online
    reputation is key to driving sales.

Third-Party Delivery Services are on the Rise

To accommodate consumer demand, restaurant operators are turning to
third-party delivery services to manage the ordering, payment and
delivery of meals. But with so many options available, it can be hard
for a restaurant operator to keep up. Understanding this pain point, the
survey asked respondents to select which delivery services they used
most often. According to the results:

  • Among third-party delivery services, Uber Eats was selected as the
    most popular (31 percent), followed by DoorDash (27 percent) and
    GrubHub (24 percent).
  • When asked what your main reasons for using third-party delivery
    services are, 50 percent of respondents cited “convenience,” followed
    by “ease of payment” (42 percent) and “good customer service” (40
    percent).
  • A quarter of respondents (25 percent), cited that they use third-party
    delivery services because they’d rather place their order online or
    via an app than talk to someone on the phone.
  • Surprisingly, the restaurant’s in-house delivery service was the
    second most used delivery service (29 percent) among general
    respondents and the number one delivery service used by respondents in
    the Southeast (28 percent) and Midwest (35 percent), proving that
    in-house delivery is still popular.

Room for Improvement

Although Americans enjoy eating out, there are a number of factors that
can contribute to a negative experience. To enable restaurant operators
to better understand the expectations of today’s restaurant patrons, the
survey asked respondents to disclose their biggest frustrations when
eating out at a restaurant and having food delivered. The survey results
showed:

  • When eating out at a restaurant, the top five frustrations for survey
    respondents include “the time it takes to receive their order” (35
    percent), “the price of the meal and getting an order wrong” (34
    percent), “not being satisfied with the quality/taste of food” (31
    percent), “rude restaurant service” (30 percent) and “restaurant
    cleanliness” (25 percent).
  • When having food delivered, the top three frustrations were “the time
    it takes for the food to be delivered” (20 percent), followed by “the
    condition of the food” (18 percent) and “missing items from my order”
    (14 percent).

“Having been in the hospitality industry for more than 30 years, it’s
interesting to see how quickly customer expectation can be changed,”
said Simon Bocca, chief operating officer at Fourth. “It’s clear from
the survey results that customer service and a tight back-of-house
operating system are key to optimizing profits. We’re excited for the
future of the industry and to continue to help restaurant operators
enhance guest satisfaction and scale profitably by ensuring they have
the right amount of labor and inventory on hand to deliver a great guest
experience – every time.”

To discover more findings from the first annual “Truth about Dining Out”
survey:

Survey Methodology:

Sponsored by Fourth, the “Truth about Dining Out” survey was conducted
by OnePoll, a marketing research company specializing in online
quantitative research and polling, between April 16-17, 2019. Feedback
was obtained from 1,000 U.S. adults who have eaten out in a restaurant
or ordered food to-go.

About Fourth:

Fourth provides complete, end-to-end restaurant and hospitality
management solutions that empower operators to optimize profits, enhance
guest satisfaction, improve employee engagement and scale profitably.
Developed by hospitality professionals for hospitality professionals,
Fourth offers an intuitive, all-in-one hospitality operations technology
platform for purchase-to-pay & inventory and workforce management –
underpinned by advanced demand forecasting, predictive analytics and
collaboration tools – as well as full-service payroll, benefits and HRO
services. Founded in 1999, Fourth serves more than 1,200 customers in 60
countries, including many notable hospitality brands in the U.S.
including Food First’s Brio & Bravo brands, Shari’s, Bolay, Pinstripes,
Bar Louie, TGI Fridays, Mandarin Oriental, Loews Hotels, Soho House and
Le Pain Quotidien. To learn more, visit www.fourth.com
or follow on Twitter @fourthnews.

Contacts

Amanda Corey
Gabriel Marketing Group
[email protected]
703.483.3678


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland

Published

on

Continue Reading

Cannabis

Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa

Published

on

Continue Reading

Innocan

Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey

Published

on

innocan-pharma-reports-breakthrough-in-a-pre-clinical-trial:-liposomal-cbd-injection-restores-mobility-to-an-amputee-female-donkey

HERZLIYA, Israel and ALGARY, AB, May 9, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the successful pre-clinical treatment with a liposomal-CBD injection in a female donkey. Innocan’s innovative therapy provided immediate noticeable pain relief and improved mobility.

Miri, a 7-year-old female donkey, underwent amputation of her right front limb at a young age, resulting in a weight burden primarily borne by her left front limb. Consequently, she developed laminitis in her left front limb, an inflammatory disease affecting the soft tissue that connects the foot bone to the hoof, seemingly causing extreme pain and limited mobility. Over time, Miri’s condition worsened, culminating in the formation of a abscess in the affected hoof, which appeared to have intensified her pain. Despite receiving pain relief medications, Miri found no respite, was unable to move, and her caregivers were advised to euthanize her.

As an act of compassionate therapy, the female donkey was administered a liposomal-CBD injection. The effect was immediate, with Miri becoming active and roaming the farm. Following the liposomal-CBD injection, the abscess in her affected foot healed, and Miri regained her ability to walk and move as she did before her laminitis developed.

“Thanks to our innovative liposomal-CBD injection, we are thrilled to have brought relief to Miri, eliminating the need for euthanasia,” commented Iris Bincovich, CEO of Innocan. “Once again, Innocan has shown liposomal-CBD to be effectively active for pain relief and well-being. We see this pre-clinical treatment as strong evidence of liposomal-CBD’s potential to improve the lives of animal patients and potentially human patients.”

“Laminitis is a crippling condition well familiar and common in horses,” said Prof Chezy Barenholz, the Chief Scientific Officer of Innocan. “The disease results in severe pain condition, representing another big market for liposomal-CBD with great potential to treat horses. Innocan is dedicated to advancing the development of CBD-based therapeutics for various indications in both humans and animals.”

For further information and a supporting video, please see: https://youtu.be/Hgqh2WOlwJQ?si=oGgSYrGi3rkW-RC

About Innocan Pharma:

Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve patients’ quality of life. This segment involves two drug delivery technologies: (i) LPT CBD-loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for two indications: Epilepsy and Pain Management. In the Consumer Wellness segment, Innocan develops and markets a wide portfolio of innovative and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a Joint Venture by the name of BI Sky Global Ltd. that focuses developing on advanced targeted online sales. https://innocanpharma.com/

Contact Information:

For Innocan Pharma Corporation:

Iris Bincovich, CEO

+1 5162104025

+972-54-3012842

+442037699377

[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution Regarding Forward-Looking Information

Certain information set forth in this news release, including, without limitation, the Company’s plans for human trials of its LPT-CBD platform, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. . The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties that could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: global and local (national) economic, political, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and potential disruption of relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import/export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release. A comprehensive discussion of other risks that impact Innocan can be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedarplus.ca.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Logo: https://mma.prnewswire.com/media/2046271/3968398/Innocan_Pharma_Corporation_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/innocan-pharma-reports-breakthrough-in-a-pre-clinical-trial-liposomal-cbd-injection-restores-mobility-to-an-amputee-female-donkey-302141590.html

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania